{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:30:16Z","timestamp":1791228616734,"version":"4.1.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","award":["2021SK53519"],"award-info":[{"award-number":["2021SK53519"]}],"id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ30791"],"award-info":[{"award-number":["2023JJ30791"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","heartrhythmjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.hrthm.2024.07.118","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:23:27Z","timestamp":1722889407000},"page":"231-239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Ruxolitinib as a CaMKII inhibitor for treatment of cardiac arrhythmias: Applications and prospects"],"prefix":"10.1016","volume":"22","author":[{"given":"Qingbo","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiran","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenghua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-3339","authenticated-orcid":false,"given":"Yichao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2024.07.118_bib1","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1182\/blood.2022017423","article-title":"Myelofibrosis","volume":"141","author":"Passamonti","year":"2023","journal-title":"Blood"},{"key":"10.1016\/j.hrthm.2024.07.118_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ajh.26050","article-title":"Primary myelofibrosis: 2021 update on diagnosis, risk-stratification and management","volume":"96","author":"Tefferi","year":"2021","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib3","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ajh.26857","article-title":"Primary myelofibrosis: 2023 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/13543784.2020.1757069","article-title":"Ruxolitinib: a potential treatment for corticosteroid refractory acute graft-versus-host disease","volume":"29","author":"Abedin","year":"2020","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.hrthm.2024.07.118_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0140-6736(20)30609-7","article-title":"Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial","volume":"396","author":"Rosmarin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.07.118_bib6","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-pharmtox-051421-111814","article-title":"CaMKII as a therapeutic target in cardiovascular disease","volume":"63","author":"Reyes Gaido","year":"2023","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.pharmthera.2016.10.006","article-title":"CaMKII as a target for arrhythmia suppression","volume":"176","author":"Mustroph","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.hrthm.2024.07.118_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abq7839","article-title":"An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor","volume":"15","author":"Reyes Gaido","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib10","doi-asserted-by":"crossref","first-page":"11551","DOI":"10.1073\/pnas.0505359102","article-title":"Mass of the postsynaptic density and enumeration of three key molecules","volume":"102","author":"Chen","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2024.07.118_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.brainresbull.2020.05.001","article-title":"Association of a CAMK2A genetic variant with logical memory performance and hippocampal volume in the elderly","volume":"161","author":"Rhein","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.hrthm.2024.07.118_bib12","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.32451","article-title":"A homozygous loss-of-function CAMK2A mutation causes growth delay, frequent seizures and severe intellectual disability","volume":"7","author":"Chia","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.hrthm.2024.07.118_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.celrep.2014.01.005","article-title":"Autonomous CaMKII mediates both LTP and LTD using a mechanism for differential substrate site selection","volume":"6","author":"Coultrap","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.hrthm.2024.07.118_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111064","article-title":"CaMKII binds both substrates and activators at the active site","volume":"40","author":"Ozden","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.hrthm.2024.07.118_bib15","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.cell.2011.07.038","article-title":"A mechanism for tunable autoinhibition in the structure of a human Ca2+\/calmodulin-dependent kinase II holoenzyme","volume":"146","author":"Chao","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.hrthm.2024.07.118_bib16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0169-328X(99)00131-X","article-title":"Developmental expression of the CaM kinase II isoforms: ubiquitous gamma- and delta-CaM kinase II are the early isoforms and most abundant in the developing nervous system","volume":"70","author":"Bayer","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib17","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-4889(94)90221-6","article-title":"Identification and characterization of \u03b4B-CaM kinase and \u03b4C-CaM kinase from rat heart, two new multifunctional Ca2+\/calmodulin-dependent protein kinase isoforms","volume":"1221","author":"Edman","year":"1994","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.hrthm.2024.07.118_bib18","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1126\/science.256.5060.1199","article-title":"Calmodulin trapping by calcium-calmodulin\u2013dependent protein kinase","volume":"256","author":"Meyer","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.hrthm.2024.07.118_bib19","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41583-022-00624-2","article-title":"CaMKII: a central molecular organizer of synaptic plasticity, learning and memory","volume":"23","author":"Yasuda","year":"2022","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.hrthm.2024.07.118_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCRESAHA.123.323571","article-title":"Nitric oxide modulates Ca2+ leak and arrhythmias via S-nitrosylation of CaMKII","volume":"133","author":"Power","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101230","article-title":"Redox-sensitive calcium\/calmodulin-dependent protein kinase II\u03b1 in angiotensin II intra-neuronal signaling and hypertension","volume":"27","author":"Basu","year":"2019","journal-title":"Redox Biol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib22","first-page":"2403","article-title":"Molecular basis for the modulation of native T-type Ca2+ channels in\u00a0vivo by Ca2+\/calmodulin-dependent protein kinase II","volume":"116","author":"Yao","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2024.07.118_bib23","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1161\/01.RES.75.5.854","article-title":"Multifunctional Ca2+\/calmodulin-dependent protein kinase mediates Ca2+-induced enhancement of the L-type Ca2+ current in rabbit ventricular myocytes","volume":"75","author":"Anderson","year":"1994","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib24","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1172\/JCI26620","article-title":"Ca2+\/calmodulin-dependent protein kinase II regulates cardiac Na+ channels","volume":"116","author":"Wagner","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2024.07.118_bib25","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/01.RES.0000249369.71709.5c","article-title":"Calmodulin kinase II inhibition shortens action potential duration by upregulation of K+ currents","volume":"99","author":"Li","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.yjmcc.2009.11.007","article-title":"\u03b2-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII\/AP-1 signaling pathway in adult cardiomyocytes","volume":"48","author":"Mani","year":"2010","journal-title":"J Mol Cell Cardiol"},{"issue":"suppl 1","key":"10.1016\/j.hrthm.2024.07.118_bib27","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF00794066","article-title":"Site-specific phosphorylation of a phospholamban peptide by cyclic nucleotide\u2013 and Ca2+\/calmodulin-dependent protein kinases of cardiac sarcoplasmic reticulum","volume":"92","author":"Karczewski","year":"1997","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib28","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1113\/jphysiol.2010.201400","article-title":"Ca2+-calmodulin\u2013dependent protein kinase II represses cardiac transcription of the L-type calcium channel \u03b11C-subunit gene (Cacna1c) by DREAM translocation","volume":"589","author":"Ronkainen","year":"2011","journal-title":"J Physiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024724","article-title":"CaMKII\u03b4B mediates aberrant NCX1 expression and the imbalance of NCX1\/SERCA in transverse aortic constriction-induced failing heart","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.hrthm.2024.07.118_bib30","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1161\/01.RES.0000125626.33738.E2","article-title":"Ca2+\/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor","volume":"94","author":"Wehrens","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib31","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.RES.0000236756.06252.13","article-title":"Ca2+\/Calmodulin-dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes","volume":"99","author":"Guo","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/europace\/euad156","article-title":"RYR2-ryanodinopathies: from calcium overload to calcium deficiency","volume":"25","author":"Steinberg","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2024.07.118_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.118.038514","article-title":"Gene therapy for catecholaminergic polymorphic ventricular tachycardia by inhibition of Ca2+\/calmodulin-dependent kinase II","volume":"140","author":"Bezzerides","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.118_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/cpdd.90","article-title":"Evaluation of the effect of ruxolitinib on cardiac repolarization: a thorough QT study","volume":"3","author":"Punwani","year":"2014","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.hrthm.2024.07.118_bib35","first-page":"1940","article-title":"Calmodulin kinase II\u2013mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice","volume":"119","author":"Chelu","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2024.07.118_bib36","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/CIRCULATIONAHA.108.788067","article-title":"Proarrhythmic defects in Timothy syndrome require calmodulin kinase II","volume":"118","author":"Thiel","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2024.07.118_bib37","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1161\/01.RES.0000194329.41863.89","article-title":"Ca2+\/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure","volume":"97","author":"Ai","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib38","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1113\/JP276757","article-title":"Molecular and tissue mechanisms of catecholaminergic polymorphic ventricular tachycardia","volume":"598","author":"Wleklinski","year":"2020","journal-title":"J Physiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib39","doi-asserted-by":"crossref","first-page":"13062","DOI":"10.1073\/pnas.0402388101","article-title":"RyR2 mutations linked to ventricular tachycardia and sudden death reduce the threshold for store-overload-induced Ca2+ release (SOICR)","volume":"101","author":"Jiang","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2024.07.118_bib40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1161\/01.RES.0000192146.85173.4b","article-title":"Enhanced store overload\u2013induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death","volume":"97","author":"Jiang","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175357","article-title":"Effect of sotagliflozin on ventricular arrhythmias in mice with myocardial infraction","volume":"936","author":"Gong","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175969","article-title":"The novel peptide athycaltide-1 attenuates Ang II\u2013induced pathological myocardial hypertrophy by reducing ROS and inhibiting the activation of CaMKII and ERK1\/2","volume":"957","author":"Zheng","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.118.007045","article-title":"Secretoneurin is an endogenous calcium\/calmodulin-dependent protein kinase II inhibitor that attenuates Ca2+-dependent arrhythmia","volume":"12","author":"Ottesen","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.119.315755","article-title":"Enhanced CaMKII-dependent late INa induces atrial proarrhythmic activity in patients with sleep-disordered breathing","volume":"126","author":"Lebek","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib45","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1073\/pnas.1523918113","article-title":"A mouse model for adult cardiac-specific gene deletion with CRISPR\/Cas9","volume":"113","author":"Carroll","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2024.07.118_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nm1215","article-title":"Calmodulin kinase II inhibition protects against structural heart disease","volume":"11","author":"Zhang","year":"2005","journal-title":"Nat Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib47","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.jmb.2019.02.001","article-title":"The KN-93 molecule inhibits calcium\/calmodulin-dependent protein kinase II (CaMKII) activity by binding to Ca2+\/CaM","volume":"431","author":"Wong","year":"2019","journal-title":"J Mol Biol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib48","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yjmcc.2017.12.015","article-title":"Improvement of cardiomyocyte function by a novel pyrimidine-based CaMKII-inhibitor","volume":"115","author":"Neef","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.yjmcc.2018.03.020","article-title":"The novel CaMKII inhibitor GS-680 reduces diastolic SR Ca leak and prevents CaMKII-dependent pro-arrhythmic activity","volume":"118","author":"Lebek","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib50","first-page":"329","article-title":"Reversion of cardiac dysfunction by a novel orally available calcium\/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy","volume":"116","author":"Beauverger","year":"2020","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib51","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jamacardio.2021.0676","article-title":"Calcium\/calmodulin-dependent protein kinase II delta inhibition and ventricular remodeling after myocardial infarction: a randomized clinical trial","volume":"6","author":"Boyle","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib52","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1074\/jbc.R000013200","article-title":"Cellular signaling through multifunctional Ca2+\/calmodulin-dependent protein kinase II","volume":"276","author":"Soderling","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2024.07.118_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan6205","article-title":"Inhalation of peptide-loaded nanoparticles improves heart failure","volume":"10","author":"Miragoli","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib54","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41551-018-0227-9","article-title":"Targeting protein and peptide therapeutics to the heart via tannic acid modification","volume":"2","author":"Shin","year":"2018","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.hrthm.2024.07.118_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe9117","article-title":"An oral antisense oligonucleotide for PCSK9 inhibition","volume":"13","author":"Gennemark","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib56","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.hrthm.2024.07.118_bib57","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1002\/cncr.34707","article-title":"Early intervention in myelofibrosis and impact on outcomes: a pooled analysis of the COMFORT-I and COMFORT-II studies","volume":"129","author":"Verstovsek","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.hrthm.2024.07.118_bib58","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib59","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib60","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jaad.2022.09.060","article-title":"Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: results from two phase 3 studies","volume":"88","author":"Papp","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib61","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0140-6736(20)32469-7","article-title":"Ruxolitinib cream for the treatment of vitiligo","volume":"396","author":"Uppal","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2024.07.118_bib62","doi-asserted-by":"crossref","first-page":"9497","DOI":"10.1073\/pnas.83.24.9497","article-title":"Activation of the multifunctional Ca2+\/calmodulin-dependent protein kinase by autophosphorylation: ATP modulates production of an autonomous enzyme","volume":"83","author":"Lou","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.hrthm.2024.07.118_bib63","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1523\/JNEUROSCI.0085-05.2005","article-title":"Visualization of synaptic Ca2+\/calmodulin-dependent protein kinase II activity in living neurons","volume":"25","author":"Takao","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.hrthm.2024.07.118_bib64","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1161\/CIRCRESAHA.111.247148","article-title":"Fluorescence resonance energy transfer\u2013based sensor Camui provides new insight into mechanisms of calcium\/calmodulin-dependent protein kinase II activation in intact cardiomyocytes","volume":"109","author":"Erickson","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib65","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1074\/jbc.RA119.009235","article-title":"FRET-based sensor for CaMKII activity (FRESCA): a useful tool for assessing CaMKII activity in response to Ca2+ oscillations in live cells","volume":"294","author":"Ardestani","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.hrthm.2024.07.118_bib66","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1177\/0091270010389469","article-title":"The pharmacokinetics, pharmacodynamics, and safety of orally dosed INCB018424 phosphate in healthy volunteers","volume":"51","author":"Shi","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib67","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1124\/dmd.110.033787","article-title":"Metabolism, excretion, and pharmacokinetics of [14C]INCB018424, a selective Janus tyrosine kinase 1\/2 inhibitor, in humans","volume":"38","author":"Shilling","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.hrthm.2024.07.118_bib68","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMoa1110556","article-title":"JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis","volume":"366","author":"Harrison","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2024.07.118_bib69","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41375-021-01261-x","article-title":"Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study","volume":"35","author":"Cervantes","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.hrthm.2024.07.118_bib70","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1182\/blood-2013-02-485888","article-title":"Three-year efficacy, safety, and survival findings from COMFORT-II, a phase 3 study comparing ruxolitinib with best available therapy for myelofibrosis","volume":"122","author":"Cervantes","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.hrthm.2024.07.118_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J Basic Clin Pharm"},{"key":"10.1016\/j.hrthm.2024.07.118_bib72","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.nbd.2016.02.007","article-title":"The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model","volume":"92","author":"Haile","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.hrthm.2024.07.118_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/BOR.0000000000000972","article-title":"Janus kinase inhibitors: efficacy and safety","volume":"35","author":"Cohen","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib74","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1097\/FJC.0000000000001470","article-title":"Cardiovascular risk management in patients treated with JAK inhibitors","volume":"83","author":"Shah","year":"2024","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.hrthm.2024.07.118_bib75","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/CIRCRESAHA.110.220418","article-title":"Inhibition of elevated Ca2+\/calmodulin-dependent protein kinase II improves contractility in human failing myocardium","volume":"107","author":"Sossalla","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib76","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1161\/01.RES.0000069686.31472.C5","article-title":"The \u03b4C isoform of CaMKII is activated in cardiac hypertrophy and induces dilated cardiomyopathy and heart failure","volume":"92","author":"Zhang","year":"2003","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib77","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1161\/CIRCRESAHA.109.203836","article-title":"CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation","volume":"106","author":"Neef","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib78","first-page":"986","article-title":"Ca2+\/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart","volume":"119","author":"Singh","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hrthm.2024.07.118_bib79","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.112.276915","article-title":"Ca2+\/Calmodulin-dependent protein kinase II \u03b4 mediates myocardial ischemia\/reperfusion injury through nuclear factor-\u03baB","volume":"112","author":"Ling","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.hrthm.2024.07.118_bib80","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1038\/s41598-019-45743-6","article-title":"Myocardial death and dysfunction after ischemia-reperfusion injury require CaMKII\u03b4 oxidation","volume":"9","author":"Wu","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.hrthm.2024.07.118_bib81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2018.10.007","article-title":"Twenty-five year trends (1986\u20132011) in hospital incidence and case-fatality rates of ventricular tachycardia and ventricular fibrillation complicating acute myocardial infarction","volume":"208","author":"Tran","year":"2019","journal-title":"Am Heart J"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124030960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527124030960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T04:01:44Z","timestamp":1735790504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527124030960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":81,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1547527124030960"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.118","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ruxolitinib as a CaMKII inhibitor for treatment of cardiac arrhythmias: Applications and prospects","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2024.07.118","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}